News and insights about UCSF’s latest biomedical discoveries and treatments helping to shape the future of medicine.
- Even in Weak Economy, Business Is Booming at UCSF Biotech Incubator July 2
- The QB3 Garage continues to see strong demand from local biotech startups, including Omniox Inc., a company whose innovative oxygen-delivery technology may someday help fight cancer and assist in trauma care.
- UCSF Clinical Pharmacy Study Is Part of FDA Acetaminophen Deliberations July 1
- Acetaminophen overdoses are still climbing. Overdoses may lead to liver failure and death. A new UCSF study informs FDA panel deliberations.
- Sugar Is a Poison, Says UCSF Obesity Expert June 25
- Sugar is a poison, says Robert Lustig, MD, UCSF obesity expert and pediatric endocrinologist.
- Depression Gene Risk Doubted June 16
- A new JAMA study questions a link between a common gene variant and depression risk among people who have experienced stressful life events. Sorting out disease risk due to genes and environment remains challenging.
- New Breast Cancer Treatments May Stem from $16.5 Million Award June 9
- A UCSF research pioneer in breast cancer – a disease that still kills about 40,000 US women each year – will co-lead a new, $16.5 million effort to develop more effective, targeted therapies to vanquish various types of breast tumors, including cancers that are particularly unresponsive to current treatments.
- Goal of Personalized Medicine for Cancer Goes Mainstream June 3
- Four experts discussed progress, hopes and challenges related to personalized cancer treatment Tuesday at UCSF’s new Helen Diller Family Cancer Research Building on the Mission Bay campus.
- Human Genome Pioneer Talks Personalized Medicine at UCSF Mission Bay June 3
- Four visionary leaders from science, industry and venture capital discussed the future of cancer research at the opening of the Helen Diller Family Cancer Research Building at Mission Bay.
- New Initiative at UCSF Targets Multiple Myeloma May 28
- The Multiple Myeloma Translational Initiative (MMTI) aims to promote collaborative research efforts and accelerate the transition of promising cancer therapies from the lab to the hospital.
- Initial Test of Bionic Leg Brace Yields Rapid Results in Patients After Stroke May 22
- After just one month of training with a new, high-tech mobility assistance device, a group of UCSF patients showed significant improvements in walking speed, balance, stride length and endurance.
- Gene Found in Sudden Sleep Disorder Implicates the Immune System May 18
- Narcolepsy, a sleep disorder that can cause sufferers to suddenly lose muscle tone and start dreaming, is an autoimmune disease, a team led by UCSF and Stanford scientists finds.
